Skip to content

Clinical trials

Phase 3 Major Depressive Disorder trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 3 Country / region: Spain Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20081
20103
20112
20122
20141
20163
20173
20201
20222
20232
20244
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting9
Terminated6
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC9
Eli Lilly and Company5
H. Lundbeck A/S4
AstraZeneca3
Neurocrine Biosciences2
Shire2
AB Biotics, SA1
Aziende Chimiche Riunite Angelini Francesco S.p.A1
Cardenal Herrera University1
Dr. Inge Winter1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder34
Anhedonia3
Depressive Disorder3
Depressive Disorder, Treatment-Resistant2
Mood Disorders2
Neurobehavioral Manifestations1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.